User profiles for G. Cooley

Christopher G. Cooley

Oakland University
Verified email at oakland.edu
Cited by 900

The identification of the weak oestrogen equol [7-hydroxy-3-(4′-hydroxyphenyl) chroman] in human urine

M Axelson, DN Kirk, RD Farrant, G Cooley… - Biochemical …, 1982 - ncbi.nlm.nih.gov
The identification (by gas chromatography–mass spectrometry and nmr) for the first time of
the weak oestrogen equol [7-hydroxy-3-(4′-hydroxyphenyl) chroman] in human urine is …

Developments in the global hydrogen market: The spectrum of hydrogen colours

M Newborough, G Cooley - Fuel Cells Bulletin, 2020 - magonlinelibrary.com
The fundamental reasons for considering the adoption of hydrogen as a fuel, industrial feedstock
and energy storage medium are presented. Hydrogen production methods are outlined…

Interpretation of the small-angle X-ray scattering from swollen and oriented perfluorinated ionomer membranes

JA Elliott, S Hanna, AMS Elliott, GE Cooley - Macromolecules, 2000 - ACS Publications
… For example, Nafion 115 has an EW of 1100 g and a thickness of 0.005 in. (127 μm). …
close to the glass transition temperature of the fluorocarbon matrix (T g,m ≅ 125 C) on “as-received” …

A novel approach to utility-scale energy storage

A Price, S Bartley, S Male, G Cooley - Power Engineering Journal, 1999 - IET
The authors describe how National Power is planning to build a 100 MWh Regenesys(TM)
energy storage plant at Didcot power station in the UK. The plant will occupy a compact site …

[HTML][HTML] Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease

…, A Armenti, AM De Rissio, G Cooley… - PLoS neglected …, 2011 - journals.plos.org
Background The main criterion for treatment effectiveness in Chagas Disease has been the
seronegative conversion, achieved many years post-treatment. One of the main limitations in …

Changes in Trypanosoma cruzi -Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy

…, G Bertocchi, MG Alvarez, G Cooley… - Clinical infectious …, 2009 - academic.oup.com
Background. As many as 20 million people are living with Trypanosoma cruzi infection in
Latin American, yet few receive any treatment. The major limitation in developing and …

Atomistic simulation and molecular dynamics of model systems for perfluorinated ionomer membranes

JA Elliott, AMS Elliott, GE Cooley - Physical Chemistry Chemical …, 1999 - pubs.rsc.org
An atomistic model for perfluorinated ionomer membranes (PIMs), in particular Nafion
materials, is presented and used in conjunction with NVT molecular dynamics simulations to …

[HTML][HTML] High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection

G Cooley, RD Etheridge, C Boehlke… - PLoS neglected …, 2008 - journals.plos.org
Background Diagnosis of Trypanosoma cruzi infection by direct pathogen detection is
complicated by the low parasite burden in subjects persistently infected with this agent of human …

[HTML][HTML] Defining seropositivity thresholds for use in trachoma elimination studies

…, H Joof, P Makalo, G Cooley… - PLoS Neglected …, 2017 - journals.plos.org
Background Efforts are underway to eliminate trachoma as a public health problem by 2020.
Programmatic guidelines are based on clinical signs that correlate poorly with Chlamydia …

The swelling behaviour of perfluorinated ionomer membranes in ethanol/water mixtures

JA Elliott, S Hanna, AMS Elliott, GE Cooley - Polymer, 2001 - Elsevier
The microscopic and bulk swelling of “Nafion ® ” perfluorinated ionomer membranes in
mixtures of ethanol and water was studied using small angle X-ray diffraction and optical …